RxDoctor Payments Data

Stephen Kennedy, MD

Family Medicine · Peru, INNPI 1700957123

Payments from drug & device makers

$444in general payments, 2019–2025

Across 23 payments — averaging $19.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$194
  • Medtronic$59
  • Corcept Therapeutics$39
  • Novo Nordisk$37
  • Exact Sciences$33
  • Lilly USA, LLC$24
  • plus $58 from 4 others

What the payments were for

  • Food & beverage$444100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$444 in reported general payments places this provider in the 45th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$54,855
Medicare patients
218
Services billed
733

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide116$134,953
EliquisApixaban115$120,004
RybelsusSemaglutide57$62,678
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt31$45,067
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$42,911
Spiriva RespimatTiotropium Bromide60$42,455
JardianceEmpagliflozin45$29,519
Tresiba Flextouch U-100Insulin Degludec35$28,098
JanumetSitagliptin Phos/Metformin Hcl23$23,152
Combivent RespimatIpratropium/Albuterol Sulfate35$20,169
CreonLipase/Protease/Amylase11$18,860
JanuviaSitagliptin Phosphate11$17,897
XareltoRivaroxaban16$17,380
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog34$14,896
Lantus SolostarInsulin Glargine,hum.Rec.Anlog70$13,902

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$37$197,631173 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$17$61,48981 claims
AbbVieCreon$194$18,86011 claims
Lilly USA, LLCTrulicity, Humalog$24$14,02332 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Peru

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →